Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001838148 | SCV001412023 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001815476 | SCV002063835 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001815476 | SCV002588438 | uncertain significance | not provided | 2022-04-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002370033 | SCV002684817 | likely benign | Cardiovascular phenotype | 2022-01-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |